drug
guaifenesin
Marketedupdated 3mo agoby Moberg Pharma AB
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 8- tagApproval40 co-mentions · 20 sources
- drugguaifenesin ER26 co-mentions · 26 sources
- tagSmall Molecule21 co-mentions · 21 sources
- tagRecall6 co-mentions · 6 sources
- drugdextromethorphan6 co-mentions · 5 sources
- drugHYDROCODONE BITARTRATE AND ACETAMINOPHEN2 co-mentions · 1 sources
- drugphenylephrine2 co-mentions · 1 sources
- drugdoxylamine1 co-mentions · 1 sources
all catalysts(0)
nothing on the calendar yet
Patent cliff
source: FDA Orange Bookfirst barrier falls
Nov 13, 2035
~9.2 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (3)
- Nov 13, 2035compositionUS 10105324
- Nov 13, 2035compositionUS 9549907
- Nov 13, 2035compositionUS 9808431
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 12m ago
Found something off?
comments(0)
5-min edit window · permanent after that